Robert F. Kennedy's overall approval rating sits at 51 percent, though the party breakdown shows a big divide between Democrats and the GOP.

U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), in a 45mg/0.5mL solution in a single-dose vial for ...

Completion of SAD/MAD trial marks advancement toward further clinical development of HT-4253 in Alzheimer's and other neurodegenerative diseases – ...

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson’s disease - ...

Pregnant women exposed to low levels of a common toxin in public drinking water-below federal safety limits-are more likely ...

Kennedy Jr. and elements of his policy agenda shows how his “Make America Healthy Again” push doesn't break down along the ...

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO THE RUSSIAN ...

Hasten Biopharmaceutical Co., Ltd. ("Hasten") announced today the completion of Market Authorization Transfers (MAT) ...

The caffenated brew could lead to healthy aging in women, while drinking soda was "strongly associated with lesser likelihood ...

As a physician-scientist, studying the pulmonary circulation has given me the opportunity to align my clinical practice ...

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson's diseasePrasinezumab is a potential first-in-class anti- ...